- Home
- PETS vs MDCX Comparison
PETS vs MDCX Comparison
Compare PETS & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.42
Company Overview
Basic Information| Metric | PETS | MDCX |
|---|---|---|
| Founded | 1996 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail-Drug Stores and Proprietary Stores | |
| Sector | Consumer Staples | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.7M | 53.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PETS | MDCX |
|---|---|---|
| Price | $3.42 | $1.51 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $3.20 | ★ $23.50 |
| AVG Volume (30 Days) | ★ 7.7M | 366.2K |
| Earning Date | 02-09-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $198,265,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.98 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.57 | $1.55 |
| 52 Week High | $5.58 | $8.94 |
Technical Indicators
Market Signals| Indicator | PETS | MDCX |
|---|---|---|
| Relative Strength Index (RSI) | 66.75 | 32.88 |
| Support Level | $1.69 | $1.68 |
| Resistance Level | $3.89 | $2.03 |
| Average True Range (ATR) | 0.39 | 0.19 |
| MACD | 0.16 | -0.03 |
| Stochastic Oscillator | 72.73 | 5.19 |
Price Performance
Historical Comparison PETS
MDCX
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.
About MDCX Medicus Pharma Ltd.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.